Positron emission tomography for detection and staging of malignant lymphoma

I Buchmann; F Moog; H Schirrmeister; S N Reske

Positron emission tomography for detection and staging of malignant lymphoma

I Buchmann, F Moog, H Schirrmeister, S N Reske

Klinik für Radiologie und Nuklearmedizin

Abstract

FDG-Positron emission tomography (FDG-PET) is an imaging modality using the physiological tracer glucose [modified as 18-fluorine-2-fluorodeoxyglucose (FDG)], whose uptake and metabolism is increased in malignant cells. While exact tumor staging in lymphomatous diseases is the basis for choosing the appropriate treatment strategy, the detection of nodal and extranodal manifestations are a key prerequisite. This study demonstrates that FDG-PET is an efficient, non-invasive method for the staging of primary untreated Hodgkin's lymphoma (HD) and non-Hodgkin's lymphoma (NHL). Clinical PET scanning is very useful in staging lymphoma patients and is more accurate than computed tomography (CT) in detecting lesions.

Originalsprache	Englisch
Zeitschrift	Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Jahrgang	156
Seiten (von - bis)	78-89
Seitenumfang	12
ISSN	0080-0015
Publikationsstatus	Veröffentlicht - 2000

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen
SDG 9 – Industrie, Innovation und Infrastruktur

Zitieren

@article{83cbabf78ea34742b434cf2a25ca0605,

title = "Positron emission tomography for detection and staging of malignant lymphoma",

abstract = "FDG-Positron emission tomography (FDG-PET) is an imaging modality using the physiological tracer glucose [modified as 18-fluorine-2-fluorodeoxyglucose (FDG)], whose uptake and metabolism is increased in malignant cells. While exact tumor staging in lymphomatous diseases is the basis for choosing the appropriate treatment strategy, the detection of nodal and extranodal manifestations are a key prerequisite. This study demonstrates that FDG-PET is an efficient, non-invasive method for the staging of primary untreated Hodgkin's lymphoma (HD) and non-Hodgkin's lymphoma (NHL). Clinical PET scanning is very useful in staging lymphoma patients and is more accurate than computed tomography (CT) in detecting lesions.",

author = "I Buchmann and F Moog and H Schirrmeister and Reske, \{S N\}",

year = "2000",

language = "English",

volume = "156",

pages = "78--89",

journal = "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer",

issn = "0080-0015",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Positron emission tomography for detection and staging of malignant lymphoma

AU - Buchmann, I

AU - Moog, F

AU - Schirrmeister, H

AU - Reske, S N

PY - 2000

Y1 - 2000

N2 - FDG-Positron emission tomography (FDG-PET) is an imaging modality using the physiological tracer glucose [modified as 18-fluorine-2-fluorodeoxyglucose (FDG)], whose uptake and metabolism is increased in malignant cells. While exact tumor staging in lymphomatous diseases is the basis for choosing the appropriate treatment strategy, the detection of nodal and extranodal manifestations are a key prerequisite. This study demonstrates that FDG-PET is an efficient, non-invasive method for the staging of primary untreated Hodgkin's lymphoma (HD) and non-Hodgkin's lymphoma (NHL). Clinical PET scanning is very useful in staging lymphoma patients and is more accurate than computed tomography (CT) in detecting lesions.

AB - FDG-Positron emission tomography (FDG-PET) is an imaging modality using the physiological tracer glucose [modified as 18-fluorine-2-fluorodeoxyglucose (FDG)], whose uptake and metabolism is increased in malignant cells. While exact tumor staging in lymphomatous diseases is the basis for choosing the appropriate treatment strategy, the detection of nodal and extranodal manifestations are a key prerequisite. This study demonstrates that FDG-PET is an efficient, non-invasive method for the staging of primary untreated Hodgkin's lymphoma (HD) and non-Hodgkin's lymphoma (NHL). Clinical PET scanning is very useful in staging lymphoma patients and is more accurate than computed tomography (CT) in detecting lesions.

M3 - Journal articles

C2 - 10802866

SN - 0080-0015

VL - 156

SP - 78

EP - 89

JO - Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

JF - Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

ER -

Positron emission tomography for detection and staging of malignant lymphoma

Abstract

UN SDGs

Fingerprint

Zitieren